FMO5 and hypogonadism: Musicki et al. reported that hypogonadism was observed in a sickle-cell anemia mouse model, which could be explained by a decreased protein expression of StAR, which impaired testosterone production via limiting the initial material of testosterone, and may be attributed to over-activation of NADPH oxidase-induced oxidative stress [33].